![Susceptibility to rifaximin and other antimicrobial agents of bacteria isolated from acute gastrointestinal infections in Mexico | Revista de Gastroenterología de México Susceptibility to rifaximin and other antimicrobial agents of bacteria isolated from acute gastrointestinal infections in Mexico | Revista de Gastroenterología de México](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//2255534X/0000008100000001/v1_201603260116/S2255534X15001152/v1_201603260116/en/main.assets/gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91RrqeQyRgaVFk/jJir8/OF+9nrJ3gdT+sy7NU1WM0lFlRMIFqUtglIRyG40dNGTva2OQzHtgVrNleTQ7lyh5C8KbyerBftQ7OWnTVg8IbZzyJNOBK9QUTPkoP15rhoTkEpF6Xk2vXHcrt9n/dmJgp0DPlD1rI/icbk3qzfzOtd63oeDkmsLp3KJaxJz+43bBpMzbFooiihqXeFHNDpLhSSrm7jYqdSKyaL8y+r13EYTr86aqJmSojg+SbF0CrurrVtMteIxcBKsjAgLeYfTa/Q=)
Susceptibility to rifaximin and other antimicrobial agents of bacteria isolated from acute gastrointestinal infections in Mexico | Revista de Gastroenterología de México
![Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature - ScienceDirect Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1198743X16306103-gr3.jpg)
Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature - ScienceDirect
![Veterinary Sciences | Free Full-Text | Fosfomycin Resistance in Bacteria Isolated from Companion Animals (Dogs and Cats) Veterinary Sciences | Free Full-Text | Fosfomycin Resistance in Bacteria Isolated from Companion Animals (Dogs and Cats)](https://pub.mdpi-res.com/vetsci/vetsci-10-00337/article_deploy/html/images/vetsci-10-00337-g001-550.jpg?1683624442)
Veterinary Sciences | Free Full-Text | Fosfomycin Resistance in Bacteria Isolated from Companion Animals (Dogs and Cats)
![Pharmaceutics | Free Full-Text | Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy Pharmaceutics | Free Full-Text | Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-02347/article_deploy/html/images/pharmaceutics-15-02347-g001.png)
Pharmaceutics | Free Full-Text | Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy
Inês Morais Vilaça on LinkedIn: The UN Climate Change 2022 report was launched, providing a comprehensive…
![TropicalMed | Free Full-Text | Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates TropicalMed | Free Full-Text | Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates](https://www.mdpi.com/tropicalmed/tropicalmed-07-00235/article_deploy/html/images/tropicalmed-07-00235-g002-550.jpg)
TropicalMed | Free Full-Text | Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates
![ES2604480T5 - 3- (6- (1- (2,2-Difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) benzoic acid pharmaceutical compositions and administration thereof - Google Patents ES2604480T5 - 3- (6- (1- (2,2-Difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) benzoic acid pharmaceutical compositions and administration thereof - Google Patents](https://patentimages.storage.googleapis.com/6c/0e/29/ef61a07821f71b/imgf000062_0001.png)